This retrospective study was carry out to asses the clinical outcome a series of 758 histologically proven basal cell carcinomas (BCCs) treated at the Plastic Surgery Units, Ferrara University, Italy in the period between January 2005 and December 2010. There were 318 (42%) females and 440 (58%) males, age ranged from 36 to 103 years with a mean value of 76 years (standard deviation ± 12 years). There were 601 (79.3%) T1 (i.e. maximum diameter less than 2 cm) and 157 (20.7%) T2 (maximum diameter comprise between 2 and 4 cm). Surgical technique was a resection and immediate suturing in 753 (99.3%) cases whereas resection plus graft was used in 5 (0.7%) patients. None had positive neck nodes (N0) and neck dissection was not performed. Histolo...
incidence of metastases is minimal, but relapses are frequent (40%-50%). The complete excision of th...
ObjectiveMohs micrographic surgery (MMS) is the treatment of choice for high-risk primary basal cell...
ObjectiveMohs micrographic surgery (MMS) is the treatment of choice for high-risk primary basal cell...
This retrospective study was carry out to asses the clinical outcome a series of 205 histologically ...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
Basal cell carcinoma (BCC) is the most frequent cutaneous malignancy in Caucasians, accounting for a...
Background: Skin cancer is the most common malignancy and makes upto about one third of all cancers ...
Background: Skin cancer is the most common malignancy and makes upto about one third of all cancers ...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
AIM: Basal Cell Carcinoma (BCC) alone accounts for 80% of cases of non-melanoma skin cancer (NMSC), ...
Aim. To analyze the results of surgical treatment and epidemiological data of patients who in 2014-2...
ObjectiveMohs micrographic surgery (MMS) is the treatment of choice for high-risk primary basal cell...
ObjectiveMohs micrographic surgery (MMS) is the treatment of choice for high-risk primary basal cell...
ObjectiveMohs micrographic surgery (MMS) is the treatment of choice for high-risk primary basal cell...
Objective. To analyze the pattern of presentation of basal cell carcinoma (BCC) and margin status fo...
incidence of metastases is minimal, but relapses are frequent (40%-50%). The complete excision of th...
ObjectiveMohs micrographic surgery (MMS) is the treatment of choice for high-risk primary basal cell...
ObjectiveMohs micrographic surgery (MMS) is the treatment of choice for high-risk primary basal cell...
This retrospective study was carry out to asses the clinical outcome a series of 205 histologically ...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
Basal cell carcinoma (BCC) is the most frequent cutaneous malignancy in Caucasians, accounting for a...
Background: Skin cancer is the most common malignancy and makes upto about one third of all cancers ...
Background: Skin cancer is the most common malignancy and makes upto about one third of all cancers ...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
AIM: Basal Cell Carcinoma (BCC) alone accounts for 80% of cases of non-melanoma skin cancer (NMSC), ...
Aim. To analyze the results of surgical treatment and epidemiological data of patients who in 2014-2...
ObjectiveMohs micrographic surgery (MMS) is the treatment of choice for high-risk primary basal cell...
ObjectiveMohs micrographic surgery (MMS) is the treatment of choice for high-risk primary basal cell...
ObjectiveMohs micrographic surgery (MMS) is the treatment of choice for high-risk primary basal cell...
Objective. To analyze the pattern of presentation of basal cell carcinoma (BCC) and margin status fo...
incidence of metastases is minimal, but relapses are frequent (40%-50%). The complete excision of th...
ObjectiveMohs micrographic surgery (MMS) is the treatment of choice for high-risk primary basal cell...
ObjectiveMohs micrographic surgery (MMS) is the treatment of choice for high-risk primary basal cell...